UBS Group
XCUR icon

UBS Group’s Exicure XCUR Stock Holding History

UBS Group’s Portfolio XCUR Stock Details XCUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$711 Sell
342
-524
-61% -$1.67K ﹤0.01% 9745
2026
Q1 		$3.69K Sell
866
-583
-40% -$2.68K ﹤0.01% 9050
2025
Q4 		$7.85K Sell
1,449
-17,253
-92% -$84.1K ﹤0.01% 8417
2025
Q3 		$76.5K Sell
18,702
-7,566
-29% -$45.6K ﹤0.01% 7285
2025
Q2 		$185K Buy
26,268
+25,702
+4,541% +$261K ﹤0.01% 6779
2025
Q1 		$7.55K Sell
566
-1,074
-65% -$11.9K ﹤0.01% 8815
2024
Q4 		$22.4K Sell
1,640
-7,948
-83% -$80.3K ﹤0.01% 7798
2024
Q3 		$33.3K Buy
9,588
+6,126
+177% +$13.7K ﹤0.01% 7075
2024
Q2 		$5.54K Buy
3,462
+3,096
+846% +$7.3K ﹤0.01% 7982
2024
Q1 		$1.1K Buy
366
+25
+7% +$78 ﹤0.01% 8227
2023
Q4 		$990 Hold
341
– – ﹤0.01% 8444
2023
Q3 		$1.23K Sell
341
-18
-5% -$84 ﹤0.01% 8034
2023
Q2 		$2.35K Sell
359
-17
-5% -$88 ﹤0.01% 7763
2023
Q1 		$1.64K Sell
376
-1,914
-84% -$11.7K ﹤0.01% 8686
2022
Q4 		$13.2K Buy
2,290
+1,965
+605% +$12.2K ﹤0.01% 8190
2022
Q3 		$3K Buy
325
+258
+385% +$2.41K ﹤0.01% 9595
2022
Q2 		$1K Sell
67
-1,177
-95% -$24.8K ﹤0.01% 9982
2022
Q1 		$37K Buy
1,244
+1,177
+1,757% +$36.1K ﹤0.01% 6802
2021
Q4 		$2K Sell
67
-129
-66% -$15K ﹤0.01% 9836
2021
Q3 		$35K Buy
196
+127
+184% +$25.7K ﹤0.01% 6627
2021
Q2 		$15K Sell
69
-78
-53% -$20.4K ﹤0.01% 7653
2021
Q1 		$48K Sell
147
-51
-26% -$17.6K ﹤0.01% 6599
2020
Q4 		$53K Buy
198
+83
+72% +$20.8K ﹤0.01% 6138
2020
Q3 		$31K Sell
115
-79
-41% -$25.8K ﹤0.01% 5976
2020
Q2 		$71K Buy
+194
New +$70.3K ﹤0.01% 5583

Other funds holding XCUR

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

UBS Group's XCUR Position: Q2 2026 in Review

UBS Group reduced its Exicure (XCUR) stake by 61% in Q2 2026, selling an estimated $1.67K and leaving 342 shares worth $711. The position accounts for ﹤0.01% of the portfolio, ranked #9745.

UBS Group first reported a position in XCUR in Q2 2020 and has held it in 25 quarters since. The position peaked at $185K in Q2 2025. 17 funds tracked by Wall St. Rank hold XCUR as of Q2 2026.

  • UBS Group held 342 shares of Exicure worth $711 as of Q2 2026.
  • UBS Group sold 524 Exicure shares in Q2 2026, an estimated $1.67K.
  • Exicure made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9745 holding.
  • UBS Group first reported a position in Exicure in Q2 2020 and has held it in 25 quarters since.
  • UBS Group's Exicure position peaked at $185K in Q2 2025.
  • 17 funds tracked by Wall St. Rank held Exicure as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.